Elaborating further, Bhushan said Zydus Cadilla completed Phase 2 clinical trials of its coronavirus vaccine in December of last year and has been granted approval for Phase 3.
A massive pan-India inoculation drive against COVID-19 was set in process with Covishield vaccine leaving Pune for 13 cities across India.
Twenty-five states and Union Territories have less than 5,000 active cases, the ministry highlighted.
The number of daily new fatalities has also declined substantially in the country. On Monday, less than 170 such deaths were recorded after 229 days, the ministry said.
The situation is being monitored and regular advice is being given to the states for enhanced surveillance, containment, testing and dispatch of samples to INSACOG laboratories.
Collaborative efforts of the Centre, states and UTs have resulted in strengthening of health facilities across the country, the health ministry said.
Comprehensive contact tracing has been initiated for co-travellers, family contacts and others, while genome sequencing on other specimens is going on, the ministry said.
The total coronavirus cases mounted to 1,04,31,639 and the death toll climbed to 1,50,798 with the novel coronavirus virus claiming 228 lives in a span of 24 hours in India.
The administrator module is for the administrators who will be conducting these vaccination sessions, Union Health Ministry said.
In the first phase, the govt will inoculate 1 crore healthcare workers, 2 crore frontline workers followed by about 27 crore people who are above 50 or have serious comorbidities.
This has been made possible as daily recoveries are outnumbering new infections for 39 days in a row, the ministry stated.
A net decline of 3,267 cases was recorded in the total active cases the previous day, the ministry said.
A dry run to assess the readiness of the mechanism was conducted successfully in Goa, Madhya Pradesh, Kerala, Delhi and Maharashtra among others.
If the genomic sequencing indicates the presence of the new variant of SARS-CoV-2, the patient will continue to remain in a separate isolation unit, it said.
The difference in the new recoveries outnumbering new cases has also improved the recovery rate to 96.08 per cent as on date.